<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: thromboembolism</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Obesity in early 20s curbs chances of reaching middle age</title>
   	 <description>Young men who are obese in their early 20s are significantly more likely to develop serious ill health by the time they reach middle age, or not even make it that far, suggests research published in the online journal BMJ Open.</description>
     <link>http://medicalxpress.com/news/2013-04-obesity-early-20s-curbs-chances.html</link>
	 <category>Overweight and Obesity</category>
	 <pubDate>Mon, 29 Apr 2013 18:56:10 EST</pubDate>
	 <guid isPermaLink="false">news286480564</guid>
	 
</item>
<item>
     <title>Study reveals risk factors for blood clots in pregnant and postnatal women</title>
   	 <description>Women who have suffered a still birth or have medical conditions including varicose veins, inflammatory bowel disease (IBD) or heart disease are at greater risk of developing dangerous blood clots after giving birth, a study has revealed.</description>
     <link>http://medicalxpress.com/news/2013-04-reveals-factors-blood-clots-pregnant.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Tue, 02 Apr 2013 10:00:01 EST</pubDate>
	 <guid isPermaLink="false">news284114097</guid>
	 
</item>
<item>
     <title>French health estimates delve into Pill risk</title>
   	 <description>A French drug watchdog on Tuesday released estimates for blood clots linked to birth control pills in the wake of fears that so-called third- and fourth-generation oral contraceptives boost a small risk of dangerous thrombosis.</description>
     <link>http://medicalxpress.com/news/2013-03-french-health-delve-pill.html</link>
	 <category>Medications</category>
	 <pubDate>Tue, 26 Mar 2013 12:00:03 EST</pubDate>
	 <guid isPermaLink="false">news283516511</guid>
	 
</item>
<item>
     <title>Study calls for research on the efficacy and safety of vena cava filters</title>
   	 <description>An evaluation of practice patterns in California hospitals showed a large variation in the use of metal devices called inferior vena cava filters, or VCFs, despite little evidence of their safety and effectiveness.</description>
     <link>http://medicalxpress.com/news/2013-03-efficacy-safety-vena-cava-filters.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 22 Mar 2013 11:30:01 EST</pubDate>
	 <guid isPermaLink="false">news283167483</guid>
	 
</item>
<item>
     <title>Study will help physicians calculate risk of post-surgical venous thromboembolisms</title>
   	 <description>New research from the UC Davis Comprehensive Cancer Center, published in the Journal of Surgical Research, may help clinicians determine which patients are at highest risk for post-surgical blood clots in the legs or lungs.</description>
     <link>http://medicalxpress.com/news/2013-03-physicians-post-surgical-venous-thromboembolisms.html</link>
	 <category>Surgery</category>
	 <pubDate>Wed, 20 Mar 2013 13:44:33 EST</pubDate>
	 <guid isPermaLink="false">news283005817</guid>
	 
</item>
<item>
     <title>Researchers find better management needed for use of IVC filters</title>
   	 <description>Researchers from Boston University School of Medicine (BUSM) have found that the use of Inferior Vena Cava (IVC) filters for the prevention and treatment of venous thrombotic events (VTE) may result in poor outcomes due to mechanical filter complications—largely due to low filter retrieval rates and inconsistent use of anticoagulants—and high rates of venous thromboembolism. The study, which was conducted at New England's largest trauma center, Boston Medical Center (BMC), currently appears on-line in JAMA Internal Medicine and is believed to be one of the first to retrospectively review retrieval options of IVC filters.</description>
     <link>http://medicalxpress.com/news/2013-03-ivc-filters.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 18 Mar 2013 16:00:06 EST</pubDate>
	 <guid isPermaLink="false">news282828673</guid>
	 
</item>
<item>
     <title>Study tracks variation between hospitals in vena cava filter use</title>
   	 <description>The frequency of vena cava filter (VCF) use to prevent migration of blood clots to the lungs in patients with acute venous thromboembolism (VTE) appears to vary widely and be associated with which hospital provides the patient care, according to a study of California hospitals published Online First by JAMA Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2013-03-tracks-variation-hospitals-vena-cava.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 18 Mar 2013 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news282828891</guid>
	 
</item>
<item>
     <title>New blood thinner beats older drug for vein clots</title>
   	 <description>(HealthDay)—People who need to take a blood thinner because they've had a clot in the deep veins of their legs appear to do better with the new drug Pradaxa (dibigatran) than with the older drug warfarin, researchers report.</description>
     <link>http://medicalxpress.com/news/2013-02-blood-thinner-older-drug-vein.html</link>
	 <category>Medications</category>
	 <pubDate>Wed, 20 Feb 2013 18:50:01 EST</pubDate>
	 <guid isPermaLink="false">news280606326</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/newbloodthin.jpg" width="90" height="90" />
</item>
<item>
     <title>Rivaroxaban found noninferior to enoxaparin in acutely ill</title>
   	 <description>(HealthDay)—In acutely ill hospitalized patients, standard-duration rivaroxaban has similar efficacy as enoxaparin in reducing the risk of venous thromboembolism, while extended-duration rivaroxaban has superior efficacy, according to a study published in the Feb. 7 issue of the New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2013-02-rivaroxaban-noninferior-enoxaparin-acutely-ill.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 07 Feb 2013 11:20:02 EST</pubDate>
	 <guid isPermaLink="false">news279457844</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/rivaroxabanf.jpg" width="90" height="90" />
</item>
<item>
     <title>Selective D-dimer testing strategy seems safe, effective</title>
   	 <description>(HealthDay)—For patients with suspected deep venous thrombosis (DVT), selective D-dimer testing is a safe and a more efficient testing strategy than universal testing, according to a study published in the Jan. 15 issue of the Annals of Internal Medicine.</description>
     <link>http://medicalxpress.com/news/2013-01-d-dimer-strategy-safe-effective.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Wed, 16 Jan 2013 13:40:01 EST</pubDate>
	 <guid isPermaLink="false">news277565311</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/selectiveddi.jpg" width="90" height="90" />
</item>
<item>
     <title>Blood clots and artery blockage more likely during IVF pregnancies</title>
   	 <description>In vitro fertilization (IVF) is associated with an increased risk of pulmonary embolism (blockage of the main artery of the lung) and venous thromboembolism (blood clots) during the first trimester of pregnancy, a study published today on BMJ website suggests.</description>
     <link>http://medicalxpress.com/news/2013-01-blood-clots-artery-blockage-ivf.html</link>
	 <category>Obstetrics &amp; gynaecology</category>
	 <pubDate>Tue, 15 Jan 2013 18:30:01 EST</pubDate>
	 <guid isPermaLink="false">news277470551</guid>
	 
</item>
<item>
     <title>France at odds with European medicines agency over Pill (Update)</title>
   	 <description>France insisted Friday on restricting the prescription of newer-generation birth control pills even as Europe's medicines watchdog declared there was no evidence to back a health warning.</description>
     <link>http://medicalxpress.com/news/2013-01-france-pressure-birth-pills.html</link>
	 <category>Medications</category>
	 <pubDate>Thu, 03 Jan 2013 11:10:53 EST</pubDate>
	 <guid isPermaLink="false">news276433847</guid>
	 
</item>
<item>
     <title>Raised risk of ischemic stroke in women with A-fib explored</title>
   	 <description>(HealthDay)—Women with atrial fibrillation (AF) have a higher risk of ischemic stroke than men with AF, related in part to differences in the percent time in the therapeutic range (TTR) associated with warfarin anticoagulation control, according to research published in the Dec. 15 issue of The American Journal of Cardiology.</description>
     <link>http://medicalxpress.com/news/2012-12-ischemic-women-a-fib-explored.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 10 Dec 2012 16:50:02 EST</pubDate>
	 <guid isPermaLink="false">news274378976</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/raisedriskof.jpg" width="90" height="90" />
</item>
<item>
     <title>New blood thinner may help prevent leg clots, study finds</title>
   	 <description>(HealthDay)—The new anti-clotting drug  apixaban (Eliquis) appears to help prevent potentially fatal blood clots in patients with deep vein thrombosis (DVT), a new Italian study finds.</description>
     <link>http://medicalxpress.com/news/2012-12-blood-thinner-leg-clots.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 10 Dec 2012 03:53:23 EST</pubDate>
	 <guid isPermaLink="false">news274333984</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-newbloodthin.jpg" width="90" height="90" />
</item>
<item>
     <title>Risk of blood clots two-fold for women with polycystic ovary syndrome on combined pill</title>
   	 <description>Women with polycystic ovary syndrome (PCOS) who are taking combined oral contraceptives have a 2-fold risk of blood clots compared with women without the disorder who take contraceptives, states a study published in CMAJ (Canadian Medical Association Journal).</description>
     <link>http://medicalxpress.com/news/2012-12-blood-clots-two-fold-women-polycystic.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 03 Dec 2012 12:00:06 EST</pubDate>
	 <guid isPermaLink="false">news273754625</guid>
	 
</item>
<item>
     <title>Aspirin a viable treatment for recurrent, serious blood clots, study shows</title>
   	 <description>(Medical Xpress)—Low-dose aspirin is a cheap and effective way to prevent potentially deadly blood clots in the leg or the lungs in patients who have had a previous blood clot, a new study shows.</description>
     <link>http://medicalxpress.com/news/2012-11-aspirin-viable-treatment-recurrent-blood.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 05 Nov 2012 07:30:40 EST</pubDate>
	 <guid isPermaLink="false">news271323030</guid>
	 
</item>
<item>
     <title>Better obesity risk prediction with hip and waist measures</title>
   	 <description>(HealthDay)—Inclusion of both waist and hip circumference as separate anthropometric measurements may improve risk prediction for obesity-related mortality and morbidity, according to research published online Oct. 17 in Obesity Reviews.</description>
     <link>http://medicalxpress.com/news/2012-10-obesity-hip-waist.html</link>
	 <category>Overweight and Obesity</category>
	 <pubDate>Wed, 24 Oct 2012 16:03:40 EST</pubDate>
	 <guid isPermaLink="false">news270313328</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/betterobesit.jpg" width="90" height="90" />
</item>
<item>
     <title>Guideline implementation may impact VTE quality of care</title>
   	 <description>The quality of care of patients hospitalized with venous thromboembolism (VTE) significantly improved between 2005 and 2009, and researchers suggest these improvements may be due to the implementation of VTE treatment guidelines.</description>
     <link>http://medicalxpress.com/news/2012-10-guideline-impact-vte-quality.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 22 Oct 2012 04:01:49 EST</pubDate>
	 <guid isPermaLink="false">news270097301</guid>
	 
</item>
<item>
     <title>Unsuspected PE seldom linked to death in cancer patients</title>
   	 <description>(HealthDay)—Unsuspected pulmonary embolism (UPE) is not associated with an increased risk of death in cancer patients when compared to patients without pulmonary embolism (PE), according to research published in the October issue of the Journal of Thrombosis and Haemostasis.</description>
     <link>http://medicalxpress.com/news/2012-10-unsuspected-pe-seldom-linked-death.html</link>
	 <category>Cancer</category>
	 <pubDate>Tue, 09 Oct 2012 19:00:01 EST</pubDate>
	 <guid isPermaLink="false">news269024229</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/1-unsuspectedp.jpg" width="90" height="90" />
</item>
<item>
     <title>Patients with rheumatoid arthritis appear to be at increased risk for blood clots</title>
   	 <description>A study that included more than 45,000 residents of Sweden with rheumatoid arthritis finds that individuals with this disease had an associated higher risk of venous thromboembolism (a blood clot that forms within a vein), and that this elevated risk was stable for 10 years after the time of diagnosis, according to a study in the October 3 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2012-10-patients-rheumatoid-arthritis-blood-clots.html</link>
	 <category>Arthritis &amp; Rheumatism</category>
	 <pubDate>Tue, 02 Oct 2012 16:00:02 EST</pubDate>
	 <guid isPermaLink="false">news268404270</guid>
	 
</item>
<item>
     <title>New findings highlight the challenges of managing blood clotting in cancer patients</title>
   	 <description>New findings that highlight the challenges of managing thromboembolic events in patients being treated for cancer were released at the ESMO 2012 Congress of the European Society for Medical Oncology in Vienna.</description>
     <link>http://medicalxpress.com/news/2012-10-highlight-blood-clotting-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 01 Oct 2012 03:31:22 EST</pubDate>
	 <guid isPermaLink="false">news268281073</guid>
	 
</item>
<item>
     <title>Undertreatment of common heart condition persists despite rapid adoption of novel therapies</title>
   	 <description>A novel blood thinner recently approved by the FDA, dabigatran (Pradaxa), has been rapidly adopted into clinical practice, yet thus far has had little impact on improving treatment rates for atrial fibrillation. This is according to a new study led by researchers from the Johns Hopkins Bloomberg School of Public Health that examined national trends in oral anticoagulant use. They found that despite rapid adoption of dabigatran for the treatment of atrial fibrillation, a large proportion of patients–two in five–did not receive oral anticoagulant therapy. In addition, although the majority of dabigatran utilization was for its FDA-approved indication, atrial fibrillation, an increasing proportion of use was for off-label indications such as venous thromboembolism. The results are featured in the September 2012 issue of Circulation: Cardiovascular Quality and Outcomes.</description>
     <link>http://medicalxpress.com/news/2012-09-undertreatment-common-heart-condition-persists.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 21 Sep 2012 16:25:54 EST</pubDate>
	 <guid isPermaLink="false">news267463547</guid>
	 
</item>
<item>
     <title>Proof of added benefit of apixaban in hip replacement</title>
   	 <description>The clot-inhibiting drug apixaban (trade name: Eliquis) was approved in May 2011 for the prevention of thrombosis (blood clots) after operations to replace a hip or knee joint. In an early benefit assessment pursuant to the &quot;Act on the Reform of the Market for Medicinal Products&quot; (AMNOG), the German Institute for Quality and Efficiency in Health Care (IQWiG) examined the added benefit of apixaban.</description>
     <link>http://medicalxpress.com/news/2012-09-proof-added-benefit-apixaban-hip.html</link>
	 <category>Medications</category>
	 <pubDate>Mon, 17 Sep 2012 10:53:40 EST</pubDate>
	 <guid isPermaLink="false">news267098004</guid>
	 
</item>
<item>
     <title>Patients underestimate risk of deep vein thrombosis, say researchers</title>
   	 <description>(Medical Xpress)—Many people going into hospital have concerns about contracting the hospital acquired infection MRSA, yet the risk of acquiring - and dying from – hospital acquired venous thromboembolism (VTE) is much greater, warn scientists at the University of Birmingham.</description>
     <link>http://medicalxpress.com/news/2012-09-patients-underestimate-deep-vein-thrombosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Mon, 03 Sep 2012 07:42:06 EST</pubDate>
	 <guid isPermaLink="false">news265876899</guid>
	 
</item>
<item>
     <title>Chronic kidney disease increases stroke risk in A-fib</title>
   	 <description>(HealthDay) -- Patients with atrial fibrillation who have chronic kidney disease are at higher risk of stroke or systemic thromboembolism and bleeding, according to a study published in the Aug. 16 issue of the New England Journal of Medicine.</description>
     <link>http://medicalxpress.com/news/2012-08-chronic-kidney-disease-a-fib.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 16 Aug 2012 10:45:38 EST</pubDate>
	 <guid isPermaLink="false">news264332729</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/chronickidne.jpg" width="90" height="90" />
</item>
<item>
     <title>Unsuspected PE does not up mortality risk in cancer patients</title>
   	 <description>(HealthDay) -- Cancer patients with an unsuspected pulmonary embolism (UPE) do not have an increased mortality risk and have a similar risk of recurrent venous thromboembolism (VTE) to those with clinically suspected pulmonary embolism (PE), according to research published online July 27 in the Journal of Thrombosis and Haemostasis.</description>
     <link>http://medicalxpress.com/news/2012-08-unsuspected-pe-mortality-cancer-patients.html</link>
	 <category>Cancer</category>
	 <pubDate>Mon, 06 Aug 2012 17:22:51 EST</pubDate>
	 <guid isPermaLink="false">news263492565</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/unsuspectedp.jpg" width="90" height="90" />
</item>
<item>
     <title>Long-term mortality risk low after cerebral vein thrombosis</title>
   	 <description>(HealthDay) -- For patients who survive a cerebral vein thrombosis (CVT), the long-term risk of mortality and recurrent venous thromboembolism (VTE) seems to be low, according to a study published in the July issue of the Journal of Thrombosis and Haemostasis.</description>
     <link>http://medicalxpress.com/news/2012-07-long-term-mortality-cerebral-vein-thrombosis.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Thu, 12 Jul 2012 12:31:03 EST</pubDate>
	 <guid isPermaLink="false">news261315030</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/longtermmort.jpg" width="90" height="90" />
</item>
<item>
     <title>Higher risk of VTE in CKD surgical patients on enoxaparin</title>
   	 <description>(HealthDay) -- For patients with chronic kidney disease (CKD) who undergo total hip replacement (THR), the rate of major venous thromboembolism (VTE) is significantly higher in those treated with enoxaparin compared to those treated with desirudin, according to a study published online June 4 in the Journal of Thrombosis and Haemostasis.</description>
     <link>http://medicalxpress.com/news/2012-06-higher-vte-ckd-surgical-patients.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 08 Jun 2012 12:30:01 EST</pubDate>
	 <guid isPermaLink="false">news258376565</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/higherriskof.jpg" width="90" height="90" />
</item>
<item>
     <title>Venous thromboembolism up in adult hospitalizations</title>
   	 <description>(HealthDay) -- Every year, more than half a million hospitalized U.S. adults acquire venous thromboembolism (VTE), a growing public health concern that is often preventable, according to research published in the June 8 issue of the U.S. Centers for Disease Control and Prevention's Morbidity &amp; Mortality Weekly Report.</description>
     <link>http://medicalxpress.com/news/2012-06-venous-thromboembolism-adult-hospitalizations.html</link>
	 <category>Diseases, Conditions, Syndromes</category>
	 <pubDate>Fri, 08 Jun 2012 05:40:01 EST</pubDate>
	 <guid isPermaLink="false">news258349358</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/venousthromb.jpg" width="90" height="90" />
</item>
<item>
     <title>Study adds to evidence on clot risks of non-oral contraceptives</title>
   	 <description>A study published on BMJ website today adds to the evidence that certain non-oral hormonal contraceptives (e.g. skin patches, implants and vaginal rings) carry a higher risk of serious blood clots (known as venous thromboembolism) than others.</description>
     <link>http://medicalxpress.com/news/2012-05-evidence-clot-non-oral-contraceptives.html</link>
	 <category>Obstetrics &amp; gynaecology</category>
	 <pubDate>Thu, 10 May 2012 18:30:05 EST</pubDate>
	 <guid isPermaLink="false">news255885607</guid>
	 
</item>


</channel>
</rss>
